SBLI partners with GRAIL

The Savings Bank Mutual Life Insurance Company of Massachusetts has launched a new pilot with healthcare company GRAIL to provide the Galleri multi-cancer early detection screening test to a select group of its Bank-Owned Life Insurance policyholders.

The Galleri test will initially be available to select SBLI BOLI policyholders, due to their impact on SBLI’s overall business, their size, and the nature in which the business is underwritten. This pilot phase will enable SBLI to gauge the impact and benefits to its customers, as it contemplates expansion of Galleri to more of its product lines in the future.

“Our partnership with GRAIL exemplifies SBLI’s ongoing focus on innovation within the insurance sector, both today and looking forward to the future. GRAIL’s groundbreaking work in early cancer detection aligns perfectly with our mission to foster the health and longevity of our customers. By offering this test, SBLI not only enhances its policy benefits but also affirms our dedication to the well-being of our policyholders.” – Jim Morgan, president and chief executive officer of SBLI.

“While doctors can screen for five specific cancers today, nearly 70% of cancer deaths are caused by cancers without recommended screening. We applaud SBLI’s leadership for their commitment to health and longevity by offering innovative cutting-edge screening technology and medical advancements like our first-of-its-kind Galleri test.” – Josh Ofman, MD, MSHS, president at GRAIL.